Siemens Healthineers AG (XETRA:SHL.DE)
| Market Cap | 42.78B-21.1% |
| Revenue (ttm) | n/a-0.9% |
| Net Income | n/a+1.9% |
| EPS | n/a+2.6% |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 216,211 |
| Open | 38.37 |
| Previous Close | 38.56 |
| Day's Range | 37.99 - 38.37 |
| 52-Week Range | 32.81 - 49.71 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About SHL.DE
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS and Novo. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$SHL.DE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in SHL.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SHL.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SHL.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New SHL.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SHL.DE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in SHL.DE
| ETF | Est. Holding Size |
|---|---|
| VXUSVanguard Total International Stock ETF | $245.66M |
| VEAVanguard FTSE Developed Markets ETF | $164.10M |
| IEFAiShares Core MSCI EAFE ETF | $108.90M |
| EFAiShares MSCI EAFE ETF | $49.96M |
| EFViShares MSCI EAFE Value ETF | $40.73M |
| VGKVanguard FTSE Europe ETF | $40.25M |
Estimated from each fund’s disclosed top holdings × AUM
SHL.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from SHL.DE’s recent data — informational, not investment advice